此页面是自动翻译的,不保证翻译的准确性。请参阅 英文版 对于源文本。

Muscle Function Following Anterior Cruciate Ligament Reconstruction: Impaired Power Output in Physically Active Individuals (ReGAIN)

2026年8月10日 更新者:Centre Hospitalier Metropole Savoie

The goal of this clinical trial is to to determine the extent of the association between objective changes in the muscle function of the knee extensors (strength and power) and the function reported by the patient following ACL reconstruction surgery. The main questions it aims to answer is:

- Pre- and post-operative (6 months) changes in maximum knee extensor strength following ACL reconstruction, correlated with the IKDC-SKF score.

研究概览

地位

招聘中

干预/治疗

详细说明

Before surgery :

  • The patient will undergo a series of assessment tests, including:
  • An assessment of the force-velocity and power-velocity relationships for each leg during a cycling task
  • An assessment of unilateral force-velocity and power-velocity relationships during a knee extension task
  • An assessment of maximum strength and explosive strength in isometric (static) mode of the knee extensors.
  • A questionnaire-based assessment of IKDC-SKF scores. Evaluations will be repeated at 3 and 6 month after surgery ; Patients will be monitored for up to 24 months following their surgery

研究类型

介入性

注册 (估计的)

110

阶段

  • 不适用

联系人和位置

本节提供了进行研究的人员的详细联系信息,以及有关进行该研究的地点的信息。

学习联系方式

学习地点

      • Challes-les-Eaux、法国、73190

参与标准

研究人员寻找符合特定描述的人,称为资格标准。这些标准的一些例子是一个人的一般健康状况或先前的治疗。

资格标准

适合学习的年龄

  • 成人
  • 年长者

接受健康志愿者

不

描述

Inclusion Criteria:

  • Patients requiring isolated or complex ACL reconstruction (combined with a meniscal injury)
  • Patients who are physically active (Tegner score ≥ 4) and wish to resume such activity.
  • Patients with no history of surgery on the ipsilateral knee (i.e., native knee).
  • Patients able to comply with the study procedures
  • Patients who have given their free and informed written consent, having been informed of the purpose of the study, its procedure and its risks.
  • Be affiliated to a social security scheme.

Exclusion Criteria:

  • Patient with comprehension difficulties
  • Recurrent rupture of the ipsilateral ACL
  • Multi-ligament injuries (i.e., injury to the medial collateral ligament, lateral collateral ligament or posterior cruciate ligament)

学习计划

本节提供研究计划的详细信息,包括研究的设计方式和研究的衡量标准。

研究是如何设计的?

设计细节

  • 主要用途:支持治疗
  • 分配:不适用
  • 介入模型:单组作业
  • 屏蔽:无(打开标签)

武器和干预

参与者组/臂
干预/治疗
实验性的:evaluated group
assessment of knee function before and after cruciate ligament surgery
  • Assessment of force-velocity and power-velocity relationships in each leg during a cycling task
  • Assessment of unilateral force-velocity and power-velocity relationships during a knee extension task
  • Assessment of maximum force and explosive force in isometric (static) conditions of the knee extensors.
  • Measurement of scores using questionnaires (IKDC-SKF).

研究衡量的是什么?

主要结果指标

结果测量
措施说明
大体时间
Correlation of maximum knee extension strength to IKDC-SKF scores
大体时间:6 month
Relationship (r coefficient) between 0-6 month delta of maximum knee extension strength measurements and International Knee Documentation Commitee-SKF scores (100: no limitation)
6 month

次要结果测量

结果测量
措施说明
大体时间
Peri-operatory trajectory of maximal dynamic force
大体时间:0, 3 and 6 month
Trajectory of evolution of F0 (maximal dynamic force) between baseline, 3 and 6 months, compared between legs (linear mixed effect model).
0, 3 and 6 month
Peri-operatory trajectory of maximal contraction velocity
大体时间:0, 3 and 6 month
Trajectory of evolution of V0 (maximal contraction velocity) between baseline, 3 and 6 months, compared between legs (linear mixed effect model).
0, 3 and 6 month
Peri-operatory trajectory of rate of force development
大体时间:0, 3 and 6 month
Trajectory of evolution of rate of force development between baseline, 3 and 6 months, compared between legs (linear mixed effect model).
0, 3 and 6 month
Peri-operatory trajectory of maximal isometric force
大体时间:0, 3 and 6 month
Trajectory of evolution of maximal isometric force (Fmax) between baseline, 3 and 6 months, compared between legs (linear mixed effect model).
0, 3 and 6 month
Peri-operatory trajectory of maximal dynamic force during cycling
大体时间:0, 3 and 6 month
Trajectory of evolution of maximal dynamic force (F0) during cycling between baseline, 3 and 6 months (linear mixed effect model, one fixed factor).
0, 3 and 6 month
Peri-operatory trajectory of maximal contraction velocity during cycling
大体时间:0, 3 and 6 month
Trajectory of evolution of maximal contraction velocity (V0) during cycling between baseline, 3 and 6 months (linear mixed effect model, one fixed factor).
0, 3 and 6 month
Determinants of fonctional prognosis
大体时间:0, 3 and 24 month

Multivariate analysis including the IKDC-SKF score at 24 months as dependant variable and, as predictors :

  1. the 0-3 month delta of V0, F0, RFD and Fmax during knee extension on the operated leg.
  2. the severity of the lesion (presence of associated lesions)
  3. the presence of a pre-operatory rehabilitation.
0, 3 and 24 month
Determinants of fonctional prognosis
大体时间:0, 3 and 24 month

Multivariate analysis including the recurrence of ACL lesion at 24 months (0/1) as dependant variable and, as predictors :

  1. the 0-3 month delta of V0, F0, RFD and Fmax during knee extension on the operated leg.
  2. the severity of the lesion (presence of associated lesions)
  3. the presence of a pre-operatory rehabilitation.
0, 3 and 24 month
Determinants of fonctional prognosis
大体时间:0, 3 and 24 month

Multivariate analysis including resuming physical activity at the pre-injury level at 24 months (0/1) as dependant variable and, as predictors :

  1. the 0-3 month delta of V0, F0, RFD and Fmax during knee extension on the operated leg.
  2. the severity of the lesion (presence of associated lesions)
  3. the presence of a pre-operatory rehabilitation.
0, 3 and 24 month

合作者和调查者

在这里您可以找到参与这项研究的人员和组织。

研究记录日期

这些日期跟踪向 ClinicalTrials.gov 提交研究记录和摘要结果的进度。研究记录和报告的结果由国家医学图书馆 (NLM) 审查,以确保它们在发布到公共网站之前符合特定的质量控制标准。

研究主要日期

学习开始 (实际的)

2026年6月8日

初级完成 (估计的)

2030年6月8日

研究完成 (估计的)

2030年6月8日

研究注册日期

首次提交

2026年6月1日

首先提交符合 QC 标准的

2026年8月10日

首次发布 (实际的)

2026年8月14日

研究记录更新

最后更新发布 (实际的)

2026年8月14日

上次提交的符合 QC 标准的更新

2026年8月10日

最后验证

2026年8月1日

更多信息

与本研究相关的术语

其他相关的 MeSH 术语

其他研究编号

  • CHMS26001

计划个人参与者数据 (IPD)

计划共享个人参与者数据 (IPD)?

不

药物和器械信息、研究文件

研究美国 FDA 监管的药品

不

研究美国 FDA 监管的设备产品

不

此信息直接从 clinicaltrials.gov 网站检索,没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求,请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改,我们的网站上也会自动更新.

订阅